Product Series
Contact Us
Domestic Business:
Pharmaceuticals:
Medical Devices:
A conventional fish-oil softgel concept for dietary omega-3 supplementation. The 1000 mg figure describes fish oil, not 1000 mg of EPA or DHA.
A soy-lecithin softgel concept. Lecithin contains a mixture of phospholipids, including phosphatidylcholine, and is used for nutritional supplementation.
A concentrated fish-derived omega-3 softgel concept with separately declared EPA and DHA. It is differentiated from the standard 1000 mg Fish Oil product.
A flaxseed-oil softgel concept featuring Linum usitatissimum seed oil. Flaxseed oil provides alpha-linolenic acid (ALA), a plant-derived omega-3 fatty acid.
An evening-primrose seed-oil softgel concept containing the omega-6 fatty acid gamma-linolenic acid (GLA).
A krill-oil softgel concept. Krill oil contains phospholipids, EPA and DHA, with naturally occurring astaxanthin contributing to its reddish appearance.
A cod-liver-oil softgel concept. It differs from ordinary fish-body oil because vitamin A and vitamin D content also needs to be considered.
A vitamin E softgel concept using the synthetic dl-alpha-tocopheryl acetate form as the formulation benchmark. Vitamin E is a fat-soluble antioxidant nutrient.
A liquid-filled calcium softgel concept. The term Liquid Calcium describes the softgel presentation; the calcium may be dispersed as a suspension rather than fully dissolved.
A broad adult multivitamin softgel concept. The formulation benchmark includes vitamins, minerals and selected accompanying nutrients, rather than a single total-mg claim.
Botanical Extract Complex Softgels
A selected botanical-complex concept based on a marketed saw-palmetto and nettle-root combination. This is one representative formula for the broad composite botanical category.
A conjugated-linoleic-acid softgel concept, using a safflower-oil-derived ingredient as the formulation benchmark.